184 related articles for article (PubMed ID: 29603832)
1. Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination programme.
Godoy P; Carmona G; Manzanares S; Jane M; Borràs E; Camps N; Álvarez J; Barrabeig I; Sala MR; Rius C; Minguell S; Carol M; Ferras J; Domínguez A;
J Viral Hepat; 2018 Sep; 25(9):1001-1007. PubMed ID: 29603832
[TBL] [Abstract][Full Text] [Related]
2. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for acute viral hepatitis--United States, 2006.
Wasley A; Grytdal S; Gallagher K;
MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A outbreaks: the effect of a mass vaccination programme.
Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
[TBL] [Abstract][Full Text] [Related]
8. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction.
Domínguez A; Oviedo M; Carmona G; Batalla J; Bruguera M; Salleras L; Plasència A
Vaccine; 2008 Mar; 26(14):1737-41. PubMed ID: 18325642
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; Rodríguez G; Galí N; Prat A
Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction.
Borràs E; Urbiztondo L; Carmona G; Jané M; Barrabeig I; Rosa Sala M; Jorgina Balañà JP; Company M; Parrón I; Godoy P; Rius C; Soldevila N; Cabezas C; Domínguez À;
Vaccine; 2019 Feb; 37(9):1137-1141. PubMed ID: 30709729
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
[TBL] [Abstract][Full Text] [Related]
12. Prospects for vaccination against hepatitis A and B in Catalonia (Spain).
Salleras L; Bruguera M; Buti M; Domíngez A
Vaccine; 2000 Feb; 18 Suppl 1():S80-2. PubMed ID: 10683557
[TBL] [Abstract][Full Text] [Related]
13. A statistical model to estimate the impact of a hepatitis A vaccination programme.
Oviedo M; Pilar Muñoz M; Domínguez A; Borras E; Carmona G
Vaccine; 2008 Nov; 26(48):6157-64. PubMed ID: 18804511
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A disease following the implementation of universal vaccination: who is at risk?
Mor Z; Srur S; Dagan R; Rishpon S
J Viral Hepat; 2010 Apr; 17(4):293-7. PubMed ID: 19691457
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
16. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
[TBL] [Abstract][Full Text] [Related]
17. Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis.
Estripeaut D; Contreras R; Tinajeros O; Castrejón MM; Shafi F; Ortega-Barria E; DeAntonio R
Vaccine; 2015 Jun; 33(28):3200-7. PubMed ID: 25981490
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a mass hepatitis A vaccination program in preadolescents.
Domínguez A; Salleras L; Carmona G; Batalla J
Vaccine; 2003 Jan; 21(7-8):698-701. PubMed ID: 12531343
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
[TBL] [Abstract][Full Text] [Related]
20. The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988-2007).
Erhart LM; Ernst KC
Vaccine; 2012 Sep; 30(42):6103-10. PubMed ID: 22835739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
